XML 14 R2.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Income Statement [Abstract]        
Net sales $ 393,066 $ 282,036 $ 1,154,119 $ 820,691
Cost of sales 294,345 202,854 842,801 617,372
Gross profit 98,721 79,182 311,318 203,319
Selling, general and administrative expenses 52,872 43,155 160,289 126,221
Research and development costs 5,677 7,352 16,379 16,757
Gain related to litigation settlement 0 0 (82,858) 0
Other (income) expenses, net (103) 4,528 1,904 11,530
Income from operations 40,275 24,147 215,604 48,811
Interest and other financial expense, net 11,456 10,768 30,366 28,656
Reclassification of actuarial losses from AOCI 1,197 2,273 3,649 7,325
Income before earnings in affiliated companies and income taxes 27,622 11,106 181,589 12,830
Income tax expense 6,753 2,250 48,517 4,006
Equity in earnings of affiliated companies, net of tax 143 141 536 426
Net income $ 21,012 $ 8,997 $ 133,608 $ 9,250
Weighted-average shares outstanding:        
Basic (in shares) 60,740 60,487 60,680 60,408
Diluted (in shares) 60,840 61,259 60,756 61,296
Earnings per share:        
Basic (in USD per share) $ 0.35 $ 0.15 $ 2.20 $ 0.15
Diluted (in USD per share) $ 0.35 $ 0.15 $ 2.20 $ 0.15